🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Join the Bioptimus team at Slush on November 20 in Helsinki! 🇫🇮 Connect with Bioptimus’ COO, Mathilda Strom, to discover how we’re developing a pioneering AI foundation model that connects biology across all scales—from molecules to cells, tissues, and entire organisms.

Our Founding Chief Operating Officer, Mathilda Strom, takes the stage of #SLUSH24 to talk Bioptimus and how we are building a pioneering AI #foundationmodel for biology. 🧬

#SLUSH24: Our Founding Chief Operating Officer, Mathilda Strom, took to the stage to spotlight Bioptimus and our groundbreaking efforts in building a pioneering AI foundation model for biology. 🧬 🎥 Watch the video below. youtube.com/watch?si=lICWH…

Sending warm holiday wishes from all of us at Bioptimus! May you and your loved ones have a safe and happy holiday season. ❄️☃️

🚨 Calling data scientists, bioinformaticians & glioblastoma researchers! Applications are OPEN for the AI Hackathon for Glioblastoma Research, Feb 3-4, 2025, at Palais Brongniart, Paris. Join 100 global experts to tackle one of the deadliest brain cancers using AI. 🌟

Next month, we're sponsoring the AI Hackathon for Glioblastoma Research, taking place on February 3-4, 2025 in Paris. This unique two-day event, presented by Servier and Owkin, will bring together 100 global experts to tackle one of the deadliest forms of brain cancer.

We’re excited to share our latest work in collaboration with Bioptimus, published as a pre-print on arXiv. Large foundation models have defined a new state-of-the-art in digital pathology. But their inference cost can be prohibitive. By applying distillation techniques to

Announcing H0-mini, our latest collaborative work with Owkin, built by applying distillation techniques to H-optimus-0. H0-mini reduces model size by several orders of magnitude and achieves comparable performance and excellent robustness. Read on arxiv: arxiv.org/abs/2501.16239

🎥 What were we striving for with our Glioblastoma Moonshot Hackathon? Why did we focus on Glioblastoma? Why do we think AI might help us bring treatments closer? Experts from the pharmaceutical, biotech and tech industry, Claude Bertrand, Martin Seifert, JP Vert, and Vincent

🇫🇷 BFM Business spotlights Bioptimus among France's hottest AI startups at #AIActionSummit. 🎧 Listen to the episode: bfmtv.com/economie/repla…

Our Co-Founder & Principal Research Scientist, Zelda Mariet, joins Heather Couture on the Impact AI podcast to discuss Bioptimus, #biology, and #foundationmodels. 🎧 Listen now: share.transistor.fm/s/8e4953c8

🧬 Can you envision a future where AI connects the dots across biology, from DNA to patients, microbes to medicine? Our Co-Founder & Principal Research Scientist, Zelda Mariet, takes the stage 🎙️ at TEDxParis to explore how foundation models are set to revolutionize medicine.

🧩 Could AI help us understand the science of life? Zelda Mariet, Bioptimus’ Co-Founder & Principal Research Scientist, takes the stage at TEDxParis to explore how foundation models are set to transform medicine. Watch the full talk → youtube.com/watch?v=nz1AcK…

📰 FRENCHWEB.FR ranks Bioptimus #3 in the WE INNOVATE 500 Startups for 2025. We're pioneering a multi-scale, multi-modal foundation model for biology. We're not just building technology, we're creating a new paradigm for biological innovation. frenchweb.fr/we-innovate-50…

🥇 H-optimus-1 ranks, on average, highest among its peers in the HEST task as well as in slide and tile-level tasks. Deep-dive into the metrics that underpin H-optimus-1’s category-leading performance in our new technical blog. Read the blog here: bioptimus.com/news/bioptimus…